|
|
| (33 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| − | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187738/?report=classic big link list published as a paper]
| |
| − | *'''[[Unproven ideas]]'''
| |
| − | *'''[[Reviews on covid19 disease]]'''
| |
| − | {{tp|p=32448490|t=ä. Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV |pdf=|usr=}}
| |
| − | {{tp|p=32413300|t=2020. (Cell-)SnapShot: COVID-19 |pdf=|usr=}} ''Covid19 at a glance with big poster''
| |
| − | {{tp|p=32346073|t=ä. COVID-19: towards understanding of pathogenesis |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | + | *'''[[Unproven ideas]]''' |
| | | | |
| | + | *'''[[Reviews on covid19 disease]]''' |
| | *'''[[Clinical guidelines and advice]]''' | | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32402434|t=ä. COVID-19 in pediatric patients: What the prehospital teams need to know |pdf=|usr=}}
| |
| − | {{tp|p=32439306|t=ä. Management and Treatment of COVID-19: The Chinese Experience |pdf=|usr=}}
| |
| − |
| |
| − | *'''[[Respiration mgmt]]'''
| |
| − | {{tp|p=C7203031|t=ä. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection? |pdf=|usr=}}
| |
| − | {{tp|p=C7144845|t=ä. Cuidado respiratorio en COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32392023|t=2020. Sedation of Mechanically Ventilated COVID-19 Patients: Challenges and Special Considerations |pdf=|usr=}}
| |
| − | {{tp|p=C7179052|t=2020. Barrier System for Airway Management of COVID-19 Patients |pdf=|usr=}}
| |
| − | {{tp|p=32446500|t=ä. Ultra-portable low-cost improvised powered air-purifying respirator: feasibility study |pdf=|usr=}}
| |
| − | {{tp|p=32414510|t=ä. Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis |pdf=|usr=}}
| |
| − | {{tp|p=32377387|t=2020. High-flow Nasal Cannula Oxygenation Revisited in COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Respiration mgmt]]''' |
| | | | |
| | *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=C7200353|t=2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection |pdf=|usr=}}
| + | |
| − | {{tp|p=C7169335|t=2020. Promising methods for detection of novel coronavirus SARS?CoV?2 |pdf=|usr=}}
| + | |
| − | {{tp|p=C7144506|t=2020. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition) |pdf=|usr=}}
| + | |
| − | {{tp|p=32382657|t=2020. Assay Techniques and Test Development for COVID-19 Diagnosis |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=32386880|t=ä. ...de las lesiones pulmonares |pdf=|usr=}}
| |
| − | {{tp|p=32381057|t=2020. CT differential diagnosis of COVID-19 and non-COVID-19 in symptomatic suspects: a practical scoring method |pdf=|usr=}}
| |
| − | {{tp|p=32416069|t=ä. Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Diagnosis (other modalities)]]''' | | *'''[[Diagnosis (other modalities)]]''' |
| − | {{tp|p=32421627|t=2020. The impact of biosensing in a pandemic outbreak: COVID-19 |pdf=|usr=}}
| |
| | | | |
| − | ----
| + | |
| | | | |
| | | | |
| | *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
| − | {{tp|p=32391184|t=2020. Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease |pdf=|usr=}}
| + | |
| − | {{tp|p=32416961|t=2020. Biochemical characterization of SARS-CoV-2 nucleocapsid protein |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Target binding and uptake]]''' | | *'''[[Target binding and uptake]]''' |
| − | {{tp|p=32451080|t=ä. A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| − | {{tp|p=32446559|t=2020. Stability of RNA sequences derived from the coronavirus genome in human cells |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| | | | |
| Zeile 65: |
Zeile 34: |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32377375|t=2020. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing |pdf=|usr=}}
| |
| − | {{tp|p=32407669|t=ä. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients |pdf=|usr=}}
| |
| − | {{tp|p=32382126|t=ä. Protective humoral immunity in SARS-CoV-2 infected pediatric patients |pdf=|usr=}}
| |
| − | {{tp|p=32382127|t=ä. NKG2A and COVID-19: another brick in the wall |pdf=|usr=}} ''we dont need no isolation we dont need no folks control''
| |
| − | {{tp|p=32235915|t=ä. COVID-19: a new challenge for human beings |pdf=|usr=}}
| |
| − | {{ttp|p=32203188|t=ä. Functional exhaustion of antiviral lymphocytes in COVID-19 patients |pdf=|usr=}}
| |
| − | {{ttp|p=32203186|t=ä. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32132669|t=ä. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV |pdf=|usr=}}
| |
| − | {{tp|p=C7064018|t=ä. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | | |
| | | | |
| | | | |
| − | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
| |
| − | {{tp|p=32387470|t=2020. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?|pdf=|usr=}}
| |
| − |
| |
| − | ----
| |
| | *'''[[Pathobiology]]''' | | *'''[[Pathobiology]]''' |
| − | {{tp|p=C7173822|t=2020. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study |pdf=|usr=}}
| |
| − | {{tp|p=32379077|t=2020. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS |pdf=|usr=}}
| |
| − | {{tp|p=32434133|t=2020. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities |pdf=|usr=}}
| |
| − | {{ttp|p=32314313|t=ä. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena?|pdf=|usr=}} ''After studying the published clinical reports, what surprised me is that most patients who had the most severe complications were affected by two comorbidities (or their long-term effects): hypertension and diabetes. Both of them induce, among other problems, '''chronic stress on endothelial cells''' that in turn can express molecules on their plasma membranes abnormally... ...In turn, these autoimmune reactions against endothelium can generate thrombosis, disseminated intravascular coagulation and multi-organ failure.''
| |
| | | | |
| | | | |
| | *'''[[Disease Models]]''' | | *'''[[Disease Models]]''' |
| − |
| |
| | | | |
| | | | |
| | *'''[[Similar diseases and pathomechanisms]]''' | | *'''[[Similar diseases and pathomechanisms]]''' |
| − | {{tp|p=32402576|t=ä. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection |pdf=|usr=}}
| + | |
| | + | |
| | | | |
| | | | |
| Zeile 102: |
Zeile 55: |
| | | | |
| | *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| − | {{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32418867|t=ä. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept |pdf=|usr=}}
| + | |
| − | {{tp|p=C7196387|t=ä. Extensive aortic thrombosis in a patient with Covid-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32386987|t=ä. Tromboembolia pulmonar aguda y enfermedad por coronavirus (COVID-19): �una asociaci�n frecuente en pacientes graves?|pdf=|usr=}}
| + | |
| | | | |
| | | | |
| Zeile 121: |
Zeile 72: |
| | | | |
| | *'''[[Neurology, ophthalmology, orl]]''' | | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=32389704|t=ä. Pain: A potential new label of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32387508|t=ä. SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis |pdf=|usr=}}
| |
| − | {{tp|p=32387343|t=ä. SARS-CoV-2: ?Three-steps? infection model and CSF diagnostic implication |pdf=|usr=}}
| |
| − | {{tp|p=32387342|t=ä. Letter to editor: Severe brain haemorrhage and concomitant COVID-19 Infection: A neurovascular complication of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Dermatology]]''' | | *'''[[Dermatology]]''' |
| − | {{tp|p=32418860|t=ä. Lesiones cuteneas tipo perniosis durante la epidemia COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32402775|t=ä. Perniosis del confinamiento, una vieja conocida en el contexto del COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Gastroenterology, hepatology]]''' | | *'''[[Gastroenterology, hepatology]]''' |
| − | {{tp|p=C7198139|t=2020. Suspected Acute Abdomen as an Extrapulmonary Manifestation of Covid-19 Infection? |pdf=|usr=}}
| |
| − | {{tp|p=C7180357|t=ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19? |pdf=|usr=}}
| |
| − | {{tp|p=C7172485|t=2020. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease |pdf=|usr=}}
| |
| | | | |
| | *'''[[Kidney, urology]]''' | | *'''[[Kidney, urology]]''' |
| | | | |
| − | | + | *'''[[The morbid survivor]]''' |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32387167|t=ä. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{tp|p=32387456|t=ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) |pdf=|usr=}}
| |
| − | {{tp|p=32402433|t=ä. Child with liver transplant recovers from COVID-19 infection A case report |pdf=|usr=}}
| |
| − | {{tp|p=32376395|t=2020. SARS-CoV-2 infection among patients with systemic autoimmune diseases |pdf=|usr=}}
| |
| − | {{tp|p=32376969|t=ä. COVID-19 outcomes in patients with hematologic disease |pdf=|usr=}}
| |
| − | {{tp|p=32386820|t=ä. Evidence of mother-to-newborn infection with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32381262|t=ä. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission |pdf=|usr=}}
| |
| − | {{tp|p=32389618|t=ä. An infant with a mild SARS-CoV-2 infection detected only by anal swabs: a case report |pdf=|usr=}}
| |
| − | {{tp|p=32382516|t=2020. Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: A case report |pdf=|usr=}}
| |
| | | | |
| | | | |
| | + | |
| | + | *'''[[Case reports]]''' |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]'''
| |
| − | {{tp|p=C7192120|t=ä. Importance of respiratory airway management as well as psychological and rehabilitative treatments to COVID-19 patients |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Case reports]]'''
| |
| − | {{tp|p=C7148978|t=ä. A Cured COVID-19 case of 86-year-old with 13 chronic diseases: A Case Report |pdf=|usr=}}
| |
| − | {{tp|p=32381283|t=ä. Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=C7165248|t=2020. Auch Kinder können schwer an COVID-19 erkranken |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Registries]]''' | | *'''[[Registries]]''' |
| Zeile 177: |
Zeile 104: |
| | | | |
| | *'''[[Trials]]''' | | *'''[[Trials]]''' |
| − |
| |
| − |
| |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32387535|t=ä. Asthma, biologics, corticosteroids, and coronavirus disease 2019 |pdf=|usr=}}
| |
| − | {{ttp|p=C7197610|t=ä. Isolation of a human monoclonal antibody specific for the receptor binding domain of SARS-CoV-2 using a competitive phage biopanning strategy |pdf=|usr=}}
| |
| − | {{tp|p=C7197606|t=ä. Antibody therapies for the treatment of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32376396|t=2020. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?|pdf=|usr=}}
| |
| − | {{tp|p=32380316|t=2020. Convalescent plasma in Covid-19: Possible mechanisms of action |pdf=|usr=}}
| |
| − | {{tp|p=32380318|t=2020. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32380315|t=2020. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis |pdf=|usr=}}
| |
| − | {{tp|p=32376392|t=2020. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions |pdf=|usr=}}
| |
| − | {{tp|p=32387040|t=ä. Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?|pdf=|usr=}}
| |
| − | {{tp|p=32389697|t=ä. Plasmapheresis treatment in COVID-19?related autoimmune meningoencephalitis: Case series |pdf=|usr=}}
| |
| − | {{tp|p=32475597|t=2020. The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32437659|t=2020. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection |pdf=|usr=}}
| |
| − | {{ttp|p=32402856|t=2020. Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2?|pdf=|usr=}}
| |
| − | {{ttp|p=32231345|t=ä. Inhibition of SARS-CoV-2 infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |pdf=|usr=}}''Here we generated a series of lipopeptides derived from EK1 and found that EK1C4 was the most potent fusion inhibitor against SARS-CoV-2 S protein-mediated membrane fusion and pseudovirus infection''
| |
| | | | |
| | | | |
| | *'''[[Other routes of infection]]''' | | *'''[[Other routes of infection]]''' |
| − | {{tp|p=32376320|t=ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=C7196379|t=ä. Droplet nuclei aerosol and Covid 19 - a risk to healthcare staff |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=C7147274|t=ä. Prevention and Treatment of Skin Damage Caused by Personal Protective Equipment: Experience of the First-Line Clinicians Treating 2019-nCoV Infection |pdf=|usr=}}
| |
| − | {{tp|p=C7148653|t=2020. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents |pdf=|usr=}}
| |
| − | {{tp|p=32389627|t=ä. Application of fluorescence method in the process of personal protective equipment removal |pdf=|usr=}}
| |
| − | {{tp|p=32409144|t=ä. A Review of Current Interventions for COVID-19 Prevention |pdf=|usr=}}
| |
| − | {{tp|p=32448491|t=ä. A Reusable Mask for Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=C7155949|t=ä. Common breaches in biosafety during donning and doffing of protective personal equipment used in the care of COVID-19 patients |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32409243|t=2020. ... oftalmologica ... |pdf=|usr=}}
| |
| − | {{tp|p=32416531|t=2020. Handling the COVID-19 pandemic: Proposing a community based toolkit for psycho-social management and preparedness |pdf=|usr=}}
| |
| − | {{tp|p=32442894|t=2020. Pandemics and psychiatry: Repositioning research in context of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32403025|t=2020. Online mental health services in Indonesia during the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32473537|t=2020. Why all COVID-19 hospitals should have mental health professionals: The importance of mental health in a worldwide crisis!|pdf=|usr=}}
| |
| − | {{tp|p=32416532|t=2020. Working in the emergency and inpatient COVID-19 special wards: A different experience for Iranian psychiatric trainees amid the outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32380441|t=2020. Psychological interventions during COVID-19: Challenges for low and middle income countries |pdf=|usr=}}
| |
| − | {{tp|p=32402477|t=2020. Telemedicine in the face of the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32386927|t=2020. Enfermedad por coronavirus 2019 (COVID-19) en Am�rica Latina: papel de la atenci�n primaria en la preparaci�n y respuesta |pdf=|usr=}}
| |
| − | {{tp|p=32376399|t=2020. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion |pdf=|usr=}}
| |
| − | {{tp|p=32380317|t=2020. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?|pdf=|usr=}}
| |
| − | {{tp|p=C7180632|t=2020. OMFS and ENT surgeons issue new COVID-19 PPE guidance |pdf=|usr=}}
| |
| − | {{tp|p=32416987|t=ä. Rapid training of healthcare staff for protected cardiopulmonary resuscitation in the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32416989|t=ä. Failure modes and effect analysis to develop transfer protocols in the management of COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32386832|t=ä. Prevention is better than the cure, but the cure cannot be worse than the disease: fibreoptic tracheal intubation in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32386837|t=ä. Percutaneous tracheostomy in patients with COVID-19: sealing the bronchoscope with an in-line suction sheath |pdf=|usr=}}
| |
| − | {{tp|p=32386835|t=ä. The Airway Lead: opportunities to improve institutional and personal preparedness for airway management |pdf=|usr=}}
| |
| − | {{tp|p=32416988|t=ä. Minimising droplet and virus spread during and after tracheal extubation |pdf=|usr=}}
| |
| − | {{tp|p=32386834|t=ä. A multipurpose portable negative air flow isolation chamber for aerosol-generating procedures during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32386833|t=ä. Considerations for resuscitation and transfer of paediatric patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32402375|t=ä. Modified tracheal extubation for patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32376006|t=ä. Rational perioperative utilisation and management during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32381261|t=ä. Equality or utility? Ethics and law of rationing ventilators |pdf=|usr=}}
| |
| − | {{tp|p=32417018|t=ä. A perspective from a NYC chief oral and maxillofacial surgery resident during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32418760|t=ä. Aerosol prevention in osteosynthesis for maxillofacial trauma ? a technical note |pdf=|usr=}}
| |
| − | {{tp|p=32386671|t=ä. Management in oral and maxillofacial surgery during the COVID-19 pandemic: Our experience |pdf=|usr=}}
| |
| − | {{tp|p=32390668|t=2020. Social Work in the Time of the COVID-19 Pandemic: All in This Together?|pdf=|usr=}}
| |
| − | {{tp|p=32416925|t=ä. ...cancer du sein ... |pdf=|usr=}}
| |
| − | {{tp|p=32387061|t=ä. COVID-19 and acute lymphoblastic leukemias of children and adolescents: ... |pdf=|usr=}}
| |
| − | {{tp|p=32387062|t=ä. ...et cancer en France... |pdf=|usr=}}
| |
| − | {{tp|p=C7192084|t=ä. Multidisciplinary management of the burn injured patient during a pandemic -? The role of telemedicine |pdf=|usr=}}
| |
| − | {{tp|p=32381447|t=2020. The role of enzymatic debridement in burn care in the COVID-19 pandemic Commentary by the Italian Society of Burn Surgery (SIUST) |pdf=|usr=}}
| |
| − | {{tp|p=C7180154|t=ä. COVID-19 pandemic and the burn survivor community: A call for action? |pdf=|usr=}}
| |
| − | {{tp|p=32416984|t=ä. Burn center function during the COVID-19 pandemic: An international multi-center report of strategy and experience |pdf=|usr=}}
| |
| − | {{tp|p=32381449|t=2020. Management strategies for the burn ward during COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7155950|t=ä. Social distancing: implications for the operating room in the face of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32380228|t=ä. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Societies |pdf=|usr=}}
| |
| − | {{tp|p=32376346|t=ä. An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience Under Real-World Suboptimal Conditions |pdf=|usr=}}
| |
| − | {{tp|p=32454025|t=ä. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer |pdf=|usr=}}
| |
| − | {{tp|p=32389580|t=2020. Radiotherapie mammaire ... |pdf=|usr=}}
| |
| − | {{tp|p=32391172|t=2020. Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − |
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| − | {{tp|p=32389696|t=ä. Psychopathological responses and face mask restrictions during the COVID-19 outbreak: Results from a nationwide survey |pdf=|usr=}}
| + | |
| − | {{tp|p=C7203163|t=ä. Sociodemographic and Psychological Correlates of Compliance with the COVID-19 Public Health Measures in France |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32454398|t=2020. STEMI during the COVID-19 Pandemic - An Evaluation of Incidence |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 282: |
Zeile 138: |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| | + | |
| | | | |
| | *'''[[Educational aspects of the status hygienicus]]''' | | *'''[[Educational aspects of the status hygienicus]]''' |
| Zeile 288: |
Zeile 145: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=C7149279|t=ä. Global implications of bio-aerosol in pandemic |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32387346|t=ä. Home quarantine or centralized quarantine, which is more conducive to fighting COVID-19 pandemic?|pdf=|usr=}}
| + | |
| − | {{tp|p=32386545|t=2020. Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| Zeile 302: |
Zeile 155: |
| | | | |
| | *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | *'''[[Failure of politics and public health guidance]]''' | | *'''[[Failure of politics and public health guidance]]''' |
| − | {{tp|p=C7184146|t=ä. COVID-19 as a Complex Intergovernmental Problem |pdf=|usr=}}
| |
| − | {{tp|p=C7184142|t=ä. Continuity of Constitutional Government during a Pandemic: Considering the Concept in Canada s Emergency Management Act |pdf=|usr=}}
| |
| − | {{tp|p=C7167486|t=ä. Public Policy and Constitutional Rights in Times of Crisis |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=C7166360|t=2015. Political Incentives to Suppress Negative Information: Evidence from Chinese Listed Firms |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| Zeile 323: |
Zeile 175: |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=C7147143|t=2020. Zwischen Infektionsschutz und Versorgungsauftrag: Eine Zwischenbilanz vier Wochen nach Ausbruch der Pandemie |pdf=|usr=}}
| |
| − | {{tp|p=32387617|t=ä. COVID-19: The first documented coronavirus pandemic in history |pdf=|usr=}}
| |
| − |
| |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32387041|t=ä. COVID-19 and Moral Imperialism in Multinational Clinical Research |pdf=|usr=}}
| |
| − | {{tp|p=32381375|t=ä. Tackling the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7204330|t=2020. Introduction to Artificial Intelligence in Economics and Finance Theories |pdf=|usr=}}
| |
| − | {{tp|p=C7152373|t=2007. Other Viral, Bacterial, Parasitic and Prion-Based Infectious Complications |pdf=|usr=}}
| |
| − | {{tp|p=32375806|t=2020. Reappraisal on pharmacological and mechanical treatments of heart failure |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Research tools]]'' | + | |
| | + | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | | | |
| | *'''[[PrePrint scene]]''' | | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| | + | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | *'''[[on-topic personal thoughts]]''' | | *'''[[on-topic personal thoughts]]''' |
